• 0
Shop Products $

Peptide CCDC98 0.05MG. Location: 15 amino acids near the amino terminus of human CCDC98, Species: Human, tested Application: Bl, Application: CCDC98 peptide is used for blocking the activity of CCDC98 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RAP80 0.05MG. Location: 17 amino acids near the carboxy terminus of human RAP80, Species: Human, tested Application: Bl, Application: RAP80 peptide is used for blocking the activity of RAP80 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RAP80 0.05MG. Location: 17 amino acids near the amino terminus of human RAP80, Species: Human, tested Application: Bl, Application: RAP80 peptide is used for blocking the activity of RAP80 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide BRCC45 0.05MG. Location: 18 amino acids near the amino terminus of human BRCC45, Species: Human, tested Application: Bl, Application: BRCC45 peptide is used for blocking the activity of BRCC45 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide BRCC36 0.05MG. Location: 16 amino acids near the amino terminus of human BRCC36, Species: Human, tested Application: Bl, Application: BRCC36 peptide is used for blocking the activity of BRCC36 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide AVIAN FLU A M2 0.05MG. Location: 15 amino acids near the amino terminus of H5N1 influenza A M2, Species: Human, tested Application: Bl, Application: Used for blocking the activity of M2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide STREP-TAG II 0.05MG. tested Application: Bl, Application: Strep-tag II peptide is used for blocking the activity of strep-tag II antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide STREP-TAG II 0.05MG. tested Application: Bl, Application: Strep-tag II peptide is used for blocking the activity of strep-tag II antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM7 0.05MG. Location: 16 amino acids near the carboxy terminus of human teM7, Tested Application: Bl, Application: teM7 peptide is used for blocking the activity of teM7 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM7 0.05MG. Location: 16 amino acids near the center of human teM7, Tested Application: Bl, Application: teM7 peptide is used for blocking the activity of teM7 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CDNF 0.05MG. Location: 9 amino acids near the carboxy terminus of human CDNF, Tested Application: Bl, Application: CDNF peptide is used for blocking the activity of CDNF antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CDNF 0.05MG. Location: 12 amino acids near the amino terminus of human CDNF, Tested Application: Bl, Application: CDNF peptide is used for blocking the activity of CDNF antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide MANF 0.05MG. Location: 12 amino acids near the carboxy terminus of human MANF, Tested Application: Bl, Application: MANF peptide is used for blocking the activity of MANF antibody.c, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide MANF 0.05MG. Location: 12 amino acids near the amino terminus of human MANF, Tested Application: Bl, Application: MANF peptide is used for blocking the activity of MANF antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGP2 0.05MG. Location: 12 amino acids near the carboxy terminus of human LGP2, Tested Application: Bl, Application: LGP2 peptide is used for blocking the activity of LGP2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGP2 0.05MG. Location: 14 amino acids near the amino terminus of human LGP2, Tested Application: Bl, Application: LGP2 peptide is used for blocking the activity of LGP2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGP2 0.05MG. Location: 11 amino acids near the center of human LGP2, Tested Application: Bl, Application: LGP2 peptide is used for blocking the activity of LGP2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM1 0.05MG. Location: 14 amino acids near the carboxy terminus of human teM1, Tested Application: Bl, Application: teM1 peptide is used for blocking the activity of teM1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM1 0.05MG. Location: 14 amino acids near the amino terminus of human teM1, Tested Application: Bl, Application: teM1 peptide is used for blocking the activity of teM1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM2 0.05MG. Location: 15 amino acids near the carboxy terminus of human teM2, Tested Application: Bl, Application: teM2 peptide is used for blocking the activity of teM2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM2 0.05MG. Location: 16 amino acids near the amino terminus of human teM2, Tested Application: Bl, Application: teM2 peptide is used for blocking the activity of teM2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM4 0.05MG. Location: 18 amino acids near the center of human teM4, Tested Application: Bl, Application: teM4 peptide is used for blocking the activity of teM4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM5 0.05MG. Location: 15 amino acids near the carboxy terminus of human teM5, Tested Application: Bl, Application: teM5 peptide is used for blocking the activity of teM5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide teM5 0.05MG. Location: 14 amino acids near the center of human teM5, Tested Application: Bl, Application: teM5 peptide is used for blocking the activity of teM5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide TOCA-1 0.05MG. Location: 17 amino acids near the carboxy terminus of human TOCA-1, Tested Application: Bl, Application: TOCA-1 peptide is used for blocking the activity of TOCA-1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide TOCA-1 0.05MG. Location: 15 amino acids near the amino terminus of human TOCA-1, Tested Application: Bl, Application: TOCA-1 peptide is used for blocking the activity of TOCA-1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide NHE-1 0.05MG. Location: 20 amino acids near the carboxy terminus of human Nhe-1, Tested Application: Bl, Application: Nhe-1 peptide is used for blocking the activity of Nhe-1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide NHE-1 0.05MG. Location: 17 amino acids near the center of human Nhe-1, Tested Application: Bl, Application: Nhe-1 peptide is used for blocking the activity of Nhe-1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK1 0.05MG. Location: 15 amino acids near the carboxy terminus of human Grik1, Tested Application: Bl, Application: Grik1 peptide is used for blocking the activity of Grik1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK1 0.05MG. Location: 16 amino acids near the center of human Grik1, Tested Application: Bl, Application: Grik1 peptide is used for blocking the activity of Grik1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK2 0.05MG. Location: 13 amino acids near the carboxy terminus of human Grik2, Tested Application: Bl, Application: Grik2 peptide is used for blocking the activity of Grik2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK3 0.05MG. Location: 13 amino acids near the amino terminus of human Grik3, Tested Application: Bl, Application: Grik3 peptide is used for blocking the activity of Grik3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK4 0.05MG. Location: 19 amino acids near the carboxy terminus of human Grik4, Tested Application: Bl, Application: Grik4 peptide is used for blocking the activity of Grik4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK4 0.05MG. Location: 14 amino acids near the amino terminus of human Grik4, Tested Application: Bl, Application: Grik4 peptide is used for blocking the activity of Grik4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GRIK5 0.05MG. Location: 17 amino acids near the carboxy terminus of human Grik5, Tested Application: Bl, Application: Grik5 peptide is used for blocking the activity of Grik5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG10 0.05MG. Location: 15 amino acids near the carboxy terminus of human ATG10, Tested Application: Bl, Application: ATG10 peptide is used for blocking the activity of ATG10 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ZBP1 0.05MG. Location: 18 amino acids near the carboxy terminus of human ZBP1, Tested Application: Bl, Application: ZBP1 peptide is used for blocking the activity of ZBP1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide FEZ2 0.05MG. Location: 15 amino acids near the carboxy terminus of human FEZ2, Tested Application: Bl, Application: FEZ2 peptide is used for blocking the activity of FEZ2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide FEZ2 0.05MG. Location: 19 amino acids near the center of human FEZ2, Tested Application: Bl, Application: FEZ2 peptide is used for blocking the activity of FEZ2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide IPR1 0.05MG. Location: 15 amino acids near the carboxy terminus of human IPR1, Tested Application: Bl, Application: IPR1 peptide is used for blocking the activity of IPR1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide IPR1 0.05MG. Location: 16 amino acids near the amino terminus of human IPR1, Tested Application: Bl, Application: IPR1 peptide is used for blocking the activity of IPR1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SAPAP3 0.05MG. Location: 18 amino acids near the carboxy terminus of human SAPAP3, Tested Application: Bl, Application: SAPAP3 peptide is used for blocking the activity of SAPAP3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide GSTP1 0.05MG. Location: 14 amino acids near the center of human GTSP1, Tested Application: Bl, Application: GSTP1 peptide is used for blocking the activity of GTSP1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide PLXDC2 0.05MG. Location: 18 amino acids near the amino terminus of human Plxdc2, Tested Application: Bl, Application: Plxdc2 peptide is used for blocking the activity of Plxdc2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide PLXDC2 0.05MG. Location: 17 amino acids near the carboxy terminus of human Plxdc2, Tested Application: Bl, Application: Plxdc2 peptide is used for blocking the activity of Plxdc2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG12 0.05MG. Location: 16 amino acids near the amino terminus of human ATG12, Tested Application: Bl, Application: ATG12 peptide is used for blocking the activity of ATG12 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG12 0.05MG. Location: 15 amino acids near the center of human ATG12, Tested Application: Bl, Application: ATG12 peptide is used for blocking the activity of ATG12 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG16 0.05MG. Location: 18 amino acids near the amino terminus of human ATG16, Tested Application: Bl, Application: ATG16 peptide is used for blocking the activity of ATG16 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG16 0.05MG. Location: 18 amino acids near the center of human ATG16.c, Tested Application: Bl, Application: ATG16 peptide is used for blocking the activity of ATG16 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CATHELICIDIN 0.05MG. Location: 17 amino acids near the carboxy terminus of human Cathelicidin, Tested Application: Bl, Application: Used for blocking the activity of Cathelicidin antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide FGF4 0.05MG. Location: 18 amino acids near the carboxy terminus of human FGF4, Tested Application: Bl, Application: FGF4 peptide is used for blocking the activity of FGF4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide ATG5 0.05MG. Location: 16 amino acids near the amino terminus of human ATG5, Tested Application: Bl, Application: ATG5 peptide is used for blocking the activity of ATG5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CXCR4-LO 0.05MG. Location: 9 amino acids near the amino terminus of isoform a of human CXCR4, Tested Application: Bl, Application: Used for blocking the activity of CXCR4-Lo antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RIM2 0.05MG. Location: 17 amino acid peptide near the center of human RIM2, Tested Application: Bl, Application: RIM2 peptide is used for blocking the activity of RIM2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SCRAPPER 0.05MG. Location: 18 amino acids near the carboxy terminus of human SCRAPPER, Tested Application: Bl, Application: SCRAPPER peptide is used for blocking the activity of SCRAPPER antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SCRAPPER 0.05MG. Location: 18 amino acids near the amino terminus of human SCRAPPER, Tested Application: Bl, Application: SCRAPPER peptide is used for blocking the activity of SCRAPPER antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK1 0.05MG. Location: 16 amino acids near the carboxy terminus of human Slitrk1, Tested Application: Bl, Application: Slitrk1 peptide is used for blocking the activity of Slitrk1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK1 0.05MG. Location: 18 amino acids near the center of human Slitrk1, Tested Application: Bl, Application: Slitrk1 peptide is used for blocking the activity of Slitrk1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK2 0.05MG. Location: 17 amino acids near the carboxy terminus of human Slitrk2, Tested Application: Bl, Application: Slitrk2 peptide is used for blocking the activity of Slitrk2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK2 0.05MG. Location: 16 amino acids near the center of human Slitrk2, Tested Application: Bl, Application: Slitrk2 peptide is used for blocking the activity of Slitrk2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK3 0.05MG. Location: 14 amino acids near the carboxy terminus of human Slitrk3, Tested Application: Bl, Application: Slitrk3 peptide is used for blocking the activity of Slitrk3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK3 0.05MG. Location: 17 amino acids near the center of human Slitrk3, Tested Application: Bl, Application: Slitrk3 peptide is used for blocking the activity of Slitrk3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RIM3 0.05MG. Location: 17 amino acids near the amino terminus of human Rim3, Tested Application: Bl, Application: Rim3 peptide is used for blocking the activity of Slitrk6 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK4 0.05MG. Location: 14 amino acids near the carboxy terminus of human Slitrk4, Tested Application: Bl, Application: Slitrk4 peptide is used for blocking the activity of Slitrk4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK5 0.05MG. Location: 14 amino acids near the center of human Slitrk5, Tested Application: Bl, Application: Slitrk5 peptide is used for blocking the activity of Slitrk5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK5 0.05MG. Location: 15 amino acids near the center of human Slitrk5, Tested Application: Bl, Application: Slitrk5 peptide is used for blocking the activity of Slitrk5 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK6 0.05MG. Location: 16 amino acids near the carboxy terminus of human Slitrk6, Tested Application: Bl, Application: Slitrk6 peptide is used for blocking the activity of Slitrk6 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK6 0.05MG. Location: 13 amino acids near the center of human Slitrk6, Tested Application: Bl, Application: Slitrk6 peptide is used for blocking the activity of Slitrk6 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SLITRK4 0.05MG. Location: 13 amino acids near the carboxy terminus of human Slitrk4, Tested Application: Bl, Application: Slitrk4 peptide is used for blocking the activity of Slitrk4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SIRT2 0.05MG. Location: 19 amino acids near the carboxy terminus of human Sirt2, Tested Application: Bl, Application: SIRT2 peptide is used for blocking the activity of Sirt2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide SIRT2 0.05MG. Location: 17 amino acids near the amino terminus of human SIRT2, Tested Application: Bl, Application: SIRT2 peptide is used for blocking the activity of SIRT2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI1 0.05MG. Location: 14 amino acids near the center of human LGI1, Tested Application: Bl, Application: LGI1 peptide is used for blocking the activity of LGI1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI2 0.05MG. Location: 11 amino acids near the amino terminus of human LGI2, Tested Application: Bl, Application: LGI2 peptide is used for blocking the activity of LGI2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI3 0.05MG. Location: 12 amino acids near the center of human LGI3, Tested Application: Bl, Application: LGI3 peptide is used for blocking the activity of LGI3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RTP801 0.05MG. Location: 12 amino acids near the center of human RTP801, Tested Application: Bl, Application: RTP801 peptide is used for blocking the activity of RTP801 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide BRAL1 0.05MG. Location: 12 amino acids near the center of human Bral1, Tested Application: Bl, Application: BRAL1 peptide is used for blocking the activity of Bral1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide BAP3 0.05MG. Location: 12 amino acids near the amino terminus of human BAP3, Tested Application: Bl, Application: BAP3 peptide is used for blocking the activity of BAP3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide BAP3 0.05MG. Location: 12 amino acids near the amino terminus of human BAP3, Tested Application: Bl, Application: BAP3 peptide is used for blocking the activity of BAP3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide RTP801 0.05MG. Location: 14 amino acids near the amino terminus of human RTP801, Tested Application: Bl, Application: RTP801 peptide is used for blocking the activity of RTP801 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI4 0.05MG. Location: 17 amino acids near the carboxy terminus of human LGI4, Tested Application: Bl, Application: LGI4 peptide is used for blocking the activity of LGI4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI4 0.05MG. Location: 14 amino acids near the center of human LGI4, Tested Application: Bl, Application: LGI4 peptide is used for blocking the activity of LGI4 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

PEPTID RIFTVALLEY FEVER V.05MG. Location: 19 amino acids near the center of RVF virus, Tested Application: Bl, Application: Used for blocking the activity of RVF virus antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

PEPTID RIFTVALLEY FEVER V.05MG. Location: 19 amino acids near the carboxy terminus of RVF virus, Tested Application: Bl, Application: Used for blocking the activity of RVF virus antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI1 0.05MG. Location: 13 amino acids near the amino terminus of human LGI1, Tested Application: Bl, Application: LGI1 peptide is used for blocking the activity of LGI1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide LGI2 0.05MG. Location: 10 amino acids near the center of human LGI2, Tested Application: Bl, Application: LGI2 peptide is used for blocking the activity of LGI2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide NIPSNAP 0.05MG. Location: 18 amino acids near the carboxy terminus of human NIPSNAP, Tested Application: Bl, Application: NIPSNAP peptide is used for blocking the activity of NIPSNAP antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide NIPSNAP 0.05MG. Location: 19 amino acids near the center of human NIPSNAP, Tested Application: Bl, Application: NIPSNAP peptide is used for blocking the activity of NIPSNAP antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide AIFM3 0.05MG. Location: 16 amino acids near the amino terminus of human AIFM3, Tested Application: Bl, Application: AIFM3 peptide is used for blocking the activity of AIFM3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide AIFM3 0.05MG. Location: 16 amino acids near the center of human AIFM3, Tested Application: Bl, Application: AIFM3 peptide is used for blocking the activity of AIFM3 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide IRGM 0.05MG. Location: 17 amino acids near the amino terminus of human IRGM, Tested Application: Bl, Application: IRGM peptide is used for blocking the activity of IRGM antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide IRGM 0.05MG. Location: 14 amino acids near the center of human IRGM, Tested Application: Bl, Application: IRGM peptide is used for blocking the activity of IRGM antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide EVER1 0.05MG. Location: 14 amino acids near the amino terminus of human EVER1, Tested Application: Bl, Application: EVER1 peptide is used for blocking the activity of EVER1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide EVER1 0.05MG. Location: 15 amino acids near the center of human EVER1, Tested Application: Bl, Application: EVER1 peptide is used for blocking the activity of EVER1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide UNC93A 0.05MG. Location: 16 amino acids near the carboxy terminus of human Unc93a, Tested Application: Bl, Application: Unc93a peptide is used for blocking the activity of Unc93a antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide UNC93B 0.05MG. Location: 19 amino acids near the amino terminus of human Unc93b, Tested Application: Bl, Application: Unc93b peptide is used for blocking the activity of Unc93b antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide AMBRA1 0.05MG. Location: 15 amino acids near the carboxy terminus of human Ambra1, Tested Application: Bl, Application: Ambra1 peptide is used for blocking the activity of Ambra1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide AMBRA1 0.05MG. Location: 18 amino acids near the amino terminus of human Ambra1, Tested Application: Bl, Application: Ambra1 peptide is used for blocking the activity of Ambra1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CAPS1 0.05MG. Location: 20 amino acids near the carboxy terminus of human CAPS1, Tested Application: Bl, Application: CAPS1 peptide is used for blocking the activity of CAPS1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CAPS1 0.05MG. Location: 21 amino acids near the amino terminus of human CAPS1, Tested Application: Bl, Application: CAPS1 peptide is used for blocking the activity of CAPS1 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Peptide CAPS2 0.05MG. Location: 19 amino acids near the center of human CAPS2, Tested Application: Bl, Application: CAPS2 peptide is used for blocking the activity of CAPS2 antibody, Concentration: 200 ug/mL, Storage Condition: At -20C, stable for one year.

Category